NCT01532037

Brief Summary

The purpose of this study is to determine if cognitive behavioural therapy (CBT) based self help is effective for the management of symptoms of fatigue in Multiple Sclerosis (MS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jun 2012

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2012

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 13, 2012

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

June 23, 2021

Status Verified

June 1, 2021

Enrollment Period

1.9 years

First QC Date

January 17, 2012

Last Update Submit

June 17, 2021

Conditions

Keywords

Randomised controlled trialMultiple SclerosisFatigueCognitive Behavioural TherapySelf Help

Outcome Measures

Primary Outcomes (1)

  • Change from baseline on ratings of the Modified Fatigue Impact Scale at post measure, 3, 6 & 12 months follow up.

    The Modified Fatigue Impact Scale (MFIS) consists of 21 items selected from the Fatigue Impact Scale (FIS; Fisk, Ritvo, Ross, Haase, Murray, \& Schlech, 1994), a multidimensional scale developed to assess the perceived impact of fatigue on a variety of daily activities. The items of the MFIS can be combined into three subscales (Physical, Cognitive, and Psychosocial), as well as into a total MFIS score. All items are scaled so that higher scores indicate a greater impact of fatigue on a patient's activities. Measures will be taken at 5 time points to assess change over time.

    5 time points at 0, 8, 20, 32 & 60 weeks.

Secondary Outcomes (3)

  • Change from baseline on the 36-Item Short Form Survey Instrument at post measure, 3, 6 and 12 months follow up.

    5 time points at 0, 8, 20, 32 & 60 weeks

  • Change from baseline on the Hospital Anxiety and Depression Scale at post measure, 3, 6 and 12 months follow up.

    5 time points at 0, 8, 20, 32 & 60 weeks

  • Change from baseline on the Self-Efficacy for managing chronic Disease 6 Item Scale at post measure, 3, 6 and 12 months follow up.

    5 time points at 0, 8, 20, 32 & 60 weeks

Study Arms (3)

Guided Self Help

EXPERIMENTAL

Participant receives usual care and 4, 45 minute sessions with a therapist to support them to complete the cognitive behavioural therapy based workbook for fatigue in Multiple Sclerosis.

Other: Cognitive behavioural therapy based self help

Pure Self Help

EXPERIMENTAL

Participant receives usual care and cognitive behavioural therapy based self help work book for fatigue in multiple sclerosis to complete alone

Other: Cognitive behavioural therapy based self help

Treatment as Usual

PLACEBO COMPARATOR

Participants receive usual care from healthcare professionals

Other: Treatment as usual

Interventions

Comparison of cognitive behavioural therapy based pure self help and guided self help (support of a therapist) compared to treatment as usual

Guided Self HelpPure Self Help

Usual care from healthcare professionals with regard to patients symptoms of fatigue

Treatment as Usual

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All participants will be aged 18 or over
  • Will have a recognised diagnosis of relapsing remitting or primary progressive relapsing remitting Multiple Sclerosis from a neurologist
  • Cognitively able to give informed consent as deemed by referring clinician in the Fife Rehabilitation Service
  • Willing to consent to randomised control trial
  • Fatigue as a primary symptom

You may not qualify if:

  • Patients with severe anxiety or depression (assessed by cut off on HADS)
  • Patients with psychosis or personality disorders (assessed by referring clinician)
  • Patients currently receiving input from psychological services for fatigue management
  • Patients with suicidal ideation or plans (assessed by referring clinician)
  • Patients who are unable to read the workbook or standardised questionnaires due to literacy levels or cognitive abilities will be excluded from the analysis, although if patients have literacy or cognitive problems, referral to a more suitable 1-to-1 type of therapy will be made.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fife Rehabilitation Service

Leven, Scotland, KY8 5RR, United Kingdom

Location

NHS Fife

Leven, Scotland, KY8 5RR, United Kingdom

Location

Related Publications (1)

  • Chapter 4 in https://era.ed.ac.uk/bitstream/handle/1842/21011/Gallen2015.pdf

    RESULT

MeSH Terms

Conditions

Multiple SclerosisFatigue

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Kirsty Nesbitt

    National Health Service, University of Edinburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2012

First Posted

February 13, 2012

Study Start

June 1, 2012

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

June 23, 2021

Record last verified: 2021-06

Locations